ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,751.11
      0.10%
      US Tech 100
      19,623.60
      0.23%
      Dow Jones
      42,347.59
      0.41%
      Brent Oil
      70.775
      -0.25%
      Bitcoin
      65,419.38
      0.36%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Janux Therapeutics Inc (JANX)

      7. Janux Therapeutics Inc (JANX) News

      JANX

      Janux Therapeutics (JANX)

      Janux Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:JANX
      DateTimeSourceHeadlineSymbolCompany
      09/26/20245:35PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JANXJanux Therapeutics Inc
      09/26/20245:13PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JANXJanux Therapeutics Inc
      09/12/20249:18PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JANXJanux Therapeutics Inc
      09/12/20249:07PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JANXJanux Therapeutics Inc
      09/10/20246:32PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JANXJanux Therapeutics Inc
      09/10/20246:26PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JANXJanux Therapeutics Inc
      09/06/20247:17PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JANXJanux Therapeutics Inc
      09/06/20247:14PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JANXJanux Therapeutics Inc
      08/09/20247:06PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:JANXJanux Therapeutics Inc
      08/07/20244:28PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:JANXJanux Therapeutics Inc
      08/07/20244:20PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:JANXJanux Therapeutics Inc
      08/07/20244:01PMBusiness WireJanux Therapeutics Reports Second Quarter 2024 Financial Results and Business HighlightsNASDAQ:JANXJanux Therapeutics Inc
      07/22/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:JANXJanux Therapeutics Inc
      07/22/20244:01PMBusiness WireJanux Therapeutics Announces Updates to Board of DirectorsNASDAQ:JANXJanux Therapeutics Inc
      06/17/20245:02PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:JANXJanux Therapeutics Inc
      06/03/20247:02PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JANXJanux Therapeutics Inc
      06/03/20247:02PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JANXJanux Therapeutics Inc
      06/03/20246:48PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JANXJanux Therapeutics Inc
      05/08/20249:13AMEdgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:JANXJanux Therapeutics Inc
      05/07/20244:01PMBusiness WireJanux Therapeutics Reports First Quarter 2024 Financial Results and Business HighlightsNASDAQ:JANXJanux Therapeutics Inc
      03/08/20244:47PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:JANXJanux Therapeutics Inc
      03/08/20244:23PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:JANXJanux Therapeutics Inc
      03/08/20244:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:JANXJanux Therapeutics Inc
      03/08/20244:01PMBusiness WireJanux Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business HighlightsNASDAQ:JANXJanux Therapeutics Inc
      02/29/20245:30PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:JANXJanux Therapeutics Inc
      02/29/20245:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:JANXJanux Therapeutics Inc
      02/29/20241:22AMBusiness WireJanux Therapeutics Announces Pricing of $296.5 Million Underwritten Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:JANXJanux Therapeutics Inc
      02/28/20249:55PMEdgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:JANXJanux Therapeutics Inc
      02/28/20245:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:JANXJanux Therapeutics Inc
      02/27/20249:50PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:JANXJanux Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:JANX